Cargando…

P02-08. Enhancement of HIV-1 DNA vaccine immunogenicity by BCG-PSN, a novel adjuvant

Detalles Bibliográficos
Autores principales:	Sun, J, Liu, Y, Li, D, Hou, J, Xu, Z, Fan, W, Fu, J, Shao, Y
Formato:	Texto
Lenguaje:	English
Publicado:	BioMed Central 2009
Materias:	Poster Presentation
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2767615/ http://dx.doi.org/10.1186/1742-4690-6-S3-P13

Ejemplares similares

CYPA, a novel and potential genetic adjuvant enhanced HIV-1 DNA vaccine immunoreactivity
por: Hou, J, et al.
Publicado: (2012)

PA02.08. Role of herbs in psychosomatic disorders
por: Ramgopal, KVRSS
Publicado: (2013)

P14-15 LB. The safety and immunogenicity of HIV-1 vaccines based on DNA and replication competent vaccinia vector in phase I clinical trial
por: Shao, Y, et al.
Publicado: (2009)

P02-06. The adjuvancy of OX40 ligand (CD252) on an HIV-1 canarypox vaccine
por: Liu, J, et al.
Publicado: (2009)

Fusion of CTA and CTB gene to immunogen significantly enhances the immunogenicity of DNA vaccine
por: Ren, X, et al.
Publicado: (2012)

P20-02. Characterization of phenotypic, genotypic and neutralization sensitivity of the HIV-1 CRF07_B'C Strains circulating in the Xinjiang Province of China
por: Ma, L, et al.
Publicado: (2009)

P04-08. Monoclonal antibodies from patient with acute HIV-1 infection
por: Chen, W, et al.
Publicado: (2009)

P02-12. Bupivacaine, a local anaesthetic, enhances immunogenicity of a multiepitopic DNA vaccine containing HIV promiscuous CD4 T cell epitopes
por: Rosa, DS, et al.
Publicado: (2009)

P08-02. Genetic variation within the gene encoding the HIV-1 CCR5 coreceptor in two South African population groups
por: Picton, AC, et al.
Publicado: (2009)

P19-17. Construction of HIV-1 AE subtype gp140 DNA vaccine and immunogenicity evaluation
por: Zhang, C, et al.
Publicado: (2009)

A pantothenate suxotroph of BCG rxpressing Gag confers enhanced HIV-specific immunogenicity compared to wildtype and perfingolysin expressing strains
por: Chetty, S, et al.
Publicado: (2012)

P08-02 Critical elements of sports programs for socially vulnerable adults: a concept mapping study
por: Alarslan, Güven, et al.
Publicado: (2022)

P17-02. PolyCTLDesigner: the software for constructing highly efficient polyepitope immunogens. Application to HIV-1
por: Antonets, D, et al.
Publicado: (2009)

P20-08. Glycosylation: an important factor in Env diversity
por: Desaire, H, et al.
Publicado: (2009)

P9.08 The Quantitative Detection of Mycobacterial Contaminations in Endoscope Reprocessors
por: Hirai, Y., et al.
Publicado: (2006)

P06-08. Building an African HIV preventive trial network
por: Price, MA, et al.
Publicado: (2009)

P02-02. Analysis of antigen specific degranulation potentials using IL-12 or IL-28B during HIV DNA Vaccination
por: Morrow, M, et al.
Publicado: (2009)

Highly expression of Tim-3 on HIV-specific T cells associated with disease progression and T-cell exhaustion in HIV-1 infected Chinese
por: Liu, Z, et al.
Publicado: (2012)

P17-12. Immunogenicity comparison of dna vaccines encompassing HIV-1 tat, rev, integrase (C-half), vif and nef genes derived from different clades
por: Wan, Y, et al.
Publicado: (2009)

P02-03. Screening of potential adjuvants for induction of pro-IgA factors
por: Buffa, V, et al.
Publicado: (2009)

P11-18. Immunogenicity of Lactobacillus gasseri-FliC as an oral mucosal vaccine adjuvant for HIV
por: Gunderson, S, et al.
Publicado: (2009)

P02.08. Patient reported outcomes from complementary, alternative, and integrative medicine (PROCAIM): a feasibility practice network study
por: Ackerman, D, et al.
Publicado: (2012)

P02-01. Elicitation of a humoral immune response towards non-immunogenic peptides using the transcriptional transactivator of HIV-1
por: Gadzinski, A, et al.
Publicado: (2009)

P02.159. EEG asymmetry, coherence, and temperament in children
por: Wang, Y, et al.
Publicado: (2012)

Skin tattooing as an effective tool for delivering DNA and protein vaccine immunogens
por: Chiu, Y, et al.
Publicado: (2012)

P18-07. Ex vivo production of autologous HIV-1 to be used as immunogen in autologous dendritic cell-based therapeutic vaccine (clinical trial DCV02)
por: Gil, C, et al.
Publicado: (2009)

Conservation of HIV-1 T cell epitopes across time and clades: validation of immunogenic HLA-A2 epitopes selected for the GAIA HIV vaccine
por: De Groot, AS, et al.
Publicado: (2012)

P02.116. The relationship between deqi and the effect of acupuncture
por: Choi, Y, et al.
Publicado: (2012)

P02.49. Dynamical system approach for CAM research
por: Ahn, A, et al.
Publicado: (2012)

HIV-1 CRF08_BC mutants resistant to reverse transcriptase inhibitors
por: Wu, Hao, et al.
Publicado: (2014)

P15-08. Did unblinding affect HIV risk behaviour and risk perception in the HVTN503/Phambili study?
por: Gray, GE, et al.
Publicado: (2009)

P02.02. Efficacy of a topical 0.1% Capsaicin hydrogel patch to treat chronic neck pain: a double-blind randomized clinical trial
por: Brodsky, M, et al.
Publicado: (2012)

Breadth or conservation score (CS): which is more important for HIV-1 T cell based vaccine immunogen design?
por: Kunwar, P, et al.
Publicado: (2012)

P19-08. Immunisation with recombinant HLA class I and II, HIV-1gp140 and SIVp27 antigens elicits protection against SHIV-SF162P4 infection in rhesus macaques
por: Mörner, A, et al.
Publicado: (2009)

P01.08. Acupuncture alleviates affective dimension of pain in a rat model of inflammatory hyperalgesia
por: Lao, L, et al.
Publicado: (2012)

P02-11. Correlate of local adjuvanticity and inflammation for experimental vaginal adjuvants in mice
por: Lindqvist, M, et al.
Publicado: (2009)

P02-08 This has just given me life back’ – mixed method evaluation of the Wild Skills, Wild Spaces ecotherapy project, Wales, UK
por: Crone, Diane, et al.
Publicado: (2022)

P02.136. A randomized controlled trial for the use of qigong in the treatment of pre and mild essential hypertension
por: Park, J, et al.
Publicado: (2012)

P17-01. HIV-specific immune responses induced by a single dose of HIV DNA vaccine in Rhesus macaques
por: Arrode-Brusés, G, et al.
Publicado: (2009)

Anti-HIV and immune modulating activities of IND02
por: Biedma, ME, et al.
Publicado: (2012)

Cannot write session to /tmp/vufind_sessions/sess_bk357cdhsff2iqajvs4q57cpbm